TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07096453: CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients

Sponsor: University of Minnesota · Phase: PHASE1/PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 30 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$9,030,400

Rescue Site Savings

+$5,954,420

Unlock Full NCT07096453 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07096453 Rescue Dossier →